{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T20:07:55Z","timestamp":1792181275785,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.humpath.2021.05.004","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T11:32:08Z","timestamp":1620819128000},"page":"74-89","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach"],"prefix":"10.1016","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-8165","authenticated-orcid":false,"given":"Adam S.","family":"Fisch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9688-3167","authenticated-orcid":false,"given":"Israa","family":"Laklouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6987-3043","authenticated-orcid":false,"given":"Masato","family":"Nakaguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e2nia","family":"Nos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2629-2289","authenticated-orcid":false,"given":"Lori J.","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Deschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Faquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1174-3972","authenticated-orcid":false,"given":"Dora","family":"Dias-Santagata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1036-6367","authenticated-orcid":false,"given":"Peter M.","family":"Sadow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2021.05.004_bib1","series-title":"WHO Classification of Head and Neck Tumours","author":"El-Naggar","year":"2017"},{"key":"10.1016\/j.humpath.2021.05.004_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1017\/S002221510009397X","article-title":"Intraductal carcinoma of the minor salivary gland","volume":"97","author":"Chen","year":"1983","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.humpath.2021.05.004_bib3","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/(SICI)1097-0142(19960901)78:5<958::AID-CNCR4>3.0.CO;2-8","article-title":"Low grade salivary duct carcinoma. A distinctive variant with a low grade histology and a predominant intraductal growth pattern","volume":"78","author":"Delgado","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2021.05.004_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1746-1596-6-122","article-title":"An invasive adenocarcinoma of the accessory parotid gland: a rare example developing from a low-grade cribriform cystadenocarcinoma?","volume":"6","author":"Nakatsuka","year":"2011","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12105-011-0256-0","article-title":"Intraductal carcinoma of salivary gland (so-called low-grade cribriform cystadenocarcinoma) arising in an intraparotid lymph node","volume":"5","author":"Weinreb","year":"2011","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/01.pas.0000128662.66321.be","article-title":"Low-grade salivary duct carcinoma: description of 16 cases","volume":"28","author":"Brandwein-Gensler","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/PAS.0000000000000952","article-title":"Recurrent RET gene rearrangements in intraductal carcinomas of salivary gland","volume":"42","author":"Weinreb","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib8","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1097\/PAS.0000000000001133","article-title":"Molecular profiling of salivary gland intraductal carcinoma revealed a subset of tumors harboring NCOA4-RET and novel TRIM27-RET fusions: a report of 17 cases","volume":"42","author":"Sk\u00e1lov\u00e1","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib9","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/PAS.0000000000001301","article-title":"NCOA4-RET and TRIM27-RET are characteristic gene fusions in salivary intraductal carcinoma, including invasive and metastatic tumors: is \u201cintraductal\u201d correct?","volume":"43","author":"Sk\u00e1lov\u00e1","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s12105-020-01128-0","article-title":"Low-grade apocrine intraductal carcinoma: expanding the morphologic and molecular spectrum of an enigmatic salivary gland tumor","volume":"14","author":"Bishop","year":"2020","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib11","article-title":"Oncocytic intraductal carcinoma of salivary glands: a distinct variant with TRIM33-RET fusions and BRAF V600E mutations","author":"Bishop","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2021.05.004_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e3181d9efcc","article-title":"Mammary analogue secretory carcinoma of salivary glands, containing the ETV6-NTRK3 fusion gene: a hitherto undescribed salivary gland tumor entity","volume":"34","author":"Sk\u00e1lov\u00e1","year":"2010","journal-title":"Am J Surg Pathol."},{"key":"10.1016\/j.humpath.2021.05.004_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00428-011-1098-6","article-title":"Mammary analogue secretory carcinoma: a new twist to the diagnostic dilemma of zymogen granule poor acinic cell carcinoma","volume":"459","author":"Griffith","year":"2011","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2021.05.004_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s12105-013-0455-y","article-title":"Mammary analogue secretory carcinoma of salivary gland origin: an update and expanded morphologic and immunohistochemical spectrum of recently described entity","volume":"7","author":"Skalova","year":"2013","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/PAS.0000000000000972","article-title":"Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation: report of 10 cases","volume":"42","author":"Skalova","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.humpath.2018.08.011","article-title":"Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family","volume":"83","author":"Guilmette","year":"2019","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib17","series-title":"AJCC Cancer Staging manual","author":"Amin","year":"2017"},{"key":"10.1016\/j.humpath.2021.05.004_bib18","unstructured":"Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM. NCCN guidelines version 1.2021, head and neck cancer. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/head-and-neck.pdf. Accessed 10 Mar 2021."},{"key":"10.1016\/j.humpath.2021.05.004_bib19","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/bioinformatics\/btu817","article-title":"GSDS 2.0: an upgraded gene feature visualization server","volume":"31","author":"Hu","year":"2015","journal-title":"Bioinforma Oxf Engl"},{"key":"10.1016\/j.humpath.2021.05.004_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/apm.13009","article-title":"Intraductal carcinomas of the salivary glands: systematic review and classification of 93 published cases","volume":"128","author":"Palicelli","year":"2020","journal-title":"APMIS"},{"key":"10.1016\/j.humpath.2021.05.004_bib21","article-title":"Salivary intraductal carcinoma arising within intraparotid lymph node: a report of 4 cases with identification of a novel STRN-ALK fusion","author":"Rooper","year":"2020","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib22","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00428-020-02823-7","article-title":"Clinicopathological study of intraductal carcinoma of the salivary gland, with emphasis on the apocrine type","volume":"477","author":"Hsieh","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2021.05.004_bib23","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/his.13517","article-title":"Low-grade intraductal carcinoma of the salivary gland with prominent oncocytic change: a newly described variant","volume":"73","author":"Nakaguro","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2021.05.004_bib24","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1158\/1078-0432.CCR-15-2568","article-title":"Profiling of 149 salivary duct carcinomas, carcinoma ex pleomorphic adenomas, and adenocarcinomas, not otherwise specified reveals actionable genomic alterations","volume":"22","author":"Wang","year":"2016","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.humpath.2021.05.004_bib25","article-title":"Low molecular weight cytokeratin immunohistochemistry reveals that most salivary gland Warthin tumors and lymphadenomas arise in intraparotid lymph nodes","author":"McLean-Holden","year":"2020","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib26","series-title":"Intraductal carcinoma of salivary gland originating from an intraparotid lymph node: a case report","first-page":"5","author":"Lin","year":"2019"},{"key":"10.1016\/j.humpath.2021.05.004_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-4608(93)90054-P","article-title":"Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in\u00a0vitro cellular behavior","volume":"65","author":"Bullerdiek","year":"1993","journal-title":"Canc Genet Cytogenet"},{"key":"10.1016\/j.humpath.2021.05.004_bib28","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/sj.onc.1201660","article-title":"The recurrent translocation t(5;8)(p13;q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter","volume":"16","author":"Voz","year":"1998","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2021.05.004_bib29","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/gcc.20619","article-title":"High-resolution genomic profiling of adenomas and carcinomas of the salivary glands reveals amplification, rearrangement, and fusion of HMGA2","volume":"48","author":"Persson","year":"2009","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2021.05.004_bib30","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/cncr.30179","article-title":"Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations: classification of Salivary Duct Carcinoma","volume":"122","author":"Chiosea","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2021.05.004_bib31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12105-012-0353-8","article-title":"PLAG1 alteration in carcinoma ex pleomorphic adenoma: immunohistochemical and fluorescence in situ hybridization studies of 22 cases","volume":"6","author":"Bahrami","year":"2012","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib32","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.humpath.2016.07.011","article-title":"Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma","volume":"57","author":"de Brito","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib33","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.humpath.2014.08.017","article-title":"Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts","volume":"46","author":"Katabi","year":"2015","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib34","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/his.12454","article-title":"Salivary duct carcinoma and the concept of early carcinoma ex pleomorphic adenoma","volume":"65","author":"Griffith","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2021.05.004_bib35","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/PAS.0000000000001605","article-title":"The myoepithelial cells of salivary intercalated duct-type intraductal carcinoma are neoplastic: a study using combined whole-slide imaging, immunofluorescence, and RET fluorescence in situ hybridization","volume":"45","author":"Bishop","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/PAS.0b013e318231542a","article-title":"Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity","volume":"36","author":"Connor","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib37","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/modpathol.2015.64","article-title":"Mammary analog secretory carcinoma, low-grade salivary duct carcinoma, and mimickers: a comparative study","volume":"28","author":"Stevens","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12105-014-0557-1","article-title":"Morphology in conjunction with immunohistochemistry is sufficient for the diagnosis of mammary analogue secretory carcinoma","volume":"9","author":"Shah","year":"2015","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib39","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001471","article-title":"Salivary secretory carcinoma harboring a novel ALK fusion: expanding the molecular characterization of carcinomas beyond the ETV6 gene","author":"Sasaki","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib40","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001535","article-title":"Expanding the molecular spectrum of secretory carcinoma of salivary glands with a novel VIM-RET fusion","author":"Sk\u00e1lov\u00e1","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib41","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s12105-019-01074-6","article-title":"Concurrent identification of novel EGFR\u2013SEPT14 fusion and ETV6\u2013RET fusion in secretory carcinoma of the salivary gland","volume":"14","author":"Black","year":"2020","journal-title":"Head Neck Pathol"},{"key":"10.1016\/j.humpath.2021.05.004_bib42","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1210\/jc.2006-1006","article-title":"Prevalence of RET\/PTC rearrangements in thyroid papillary carcinomas: effects of the detection methods and genetic heterogeneity","volume":"91","author":"Zhu","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2021.05.004_bib43","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1210\/jc.2006-0791","article-title":"RET\/PTC rearrangement\u2013a link between Hashimoto's thyroiditis and thyroid cancer...or not","volume":"91","author":"Nikiforov","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.humpath.2021.05.004_bib44","first-page":"468","article-title":"Comprehensive analysis of RET and ROS1 rearrangement in lung adenocarcinoma","volume":"28","author":"Lee","year":"2015","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.humpath.2021.05.004_bib45","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1038\/s41467-018-07341-4","article-title":"RET rearrangements are actionable alterations in breast cancer","volume":"9","author":"Paratala","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2021.05.004_bib46","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1038\/onc.2016.483","article-title":"Upregulation of RET induces perineurial invasion of pancreatic adenocarcinoma","volume":"36","author":"Amit","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2021.05.004_bib47","article-title":"Identifying novel oncogenic RET mutations and characterising their sensitivity to RET-specific inhibitors","author":"Zhao","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/j.humpath.2021.05.004_bib48","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1158\/1078-0432.CCR-16-1679","article-title":"RET aberrations in diverse cancers: next-generation sequencing of 4,871 patients","volume":"23","author":"Kato","year":"2017","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.humpath.2021.05.004_bib49","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/1097-0142(19881101)62:9<1899::AID-CNCR2820620905>3.0.CO;2-C","article-title":"Metastatic medullary thyroid carcinoma: complete response to combination chemotherapy with dacarbazine and 5-fluorouracil","volume":"62","author":"Petursson","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2021.05.004_bib50","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2021.05.004_bib51","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2021.05.004_bib52","doi-asserted-by":"crossref","first-page":"v933","DOI":"10.1093\/annonc\/mdz394.093","article-title":"Registrational results of LOXO-292 in patients with RET-altered thyroid cancers","volume":"30","author":"Wirth","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.humpath.2021.05.004_bib53","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1158\/2159-8290.CD-18-0338","article-title":"Precision targeted therapy with BLU-667 for RET-driven cancers","volume":"8","author":"Subbiah","year":"2018","journal-title":"Canc Discov"},{"key":"10.1016\/j.humpath.2021.05.004_bib54","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2021.05.004_bib55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1158\/2159-8290.CD-19-1116","article-title":"Advances in targeting RET-dependent cancers","volume":"10","author":"Subbiah","year":"2020","journal-title":"Canc Discov"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817721000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T16:38:54Z","timestamp":1758645534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817721000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":55,"alternative-id":["S0046817721000770"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2021.05.004","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraductal carcinoma of the salivary gland with NCOA4-RET: expanding the morphologic spectrum and an algorithmic diagnostic approach","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2021.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}